CRISPR-Cas systems for genome editing, regulation and targeting

Explore this paper's citation graph

Summary

A modified version of the CRISPR-Cas9 system has been developed to recruit heterologous domains that can regulate endogenous gene expression or label specific genomic loci in living cells, which will undoubtedly transform biological research and spur the development of novel molecular therapeutics for human disease.

Type
review
Published
2014-03-02
Cited by
3,002
References
105
Access
Open access

Keywords

CRISPR, Genome editing, Cas9, Biology, Computational biology

References

Cited by

Related papers